期刊文献+

靶向干扰CDK2AP1对乳腺癌MCF-7细胞体外迁移和侵袭的影响

CDK2AP1 knockdown inhibits migration and invasion of human breast cancer MCF-7 cell line in vitro
下载PDF
导出
摘要 目的探讨靶向干扰细胞周期调节蛋白依赖性激酶2-关联蛋白-1(CDK2AP1)对乳腺癌MCF-7胞体外迁移和侵袭的影响。方法构建重组慢病毒pGCLV-CDK2AP1-shRNA及重组空病毒pGCLV-GFP,分别稳定转染乳腺癌细胞系MCF-7,获得乳腺癌细胞株MCF-7/RNAi-NC和MCF-7/RNAi-CDK2AP1。采用定量PCR法检测两组MCF-7细胞株的CDK2AP1mRNA表达,xCELLigence/RT-CIM实时细胞电子分析系统检测细胞迁移能力,Transwell实验检测细胞的侵袭能力。结果成功构建乳腺癌细胞株MCF-7/RNAi-NC和MCF-7/RNAi-CDK2AP1,相比MCF-7/RNAi-NC细胞组,MCF-7/RNAi-CDK2AP1细胞组的CDK2AP1mRNA表达受到明显抑制,其细胞迁移和侵袭能力均显著下降(P<0.05)。结论乳腺癌细胞MCF-7中CDK2AP1低表达能有效抑制细胞的体外迁移和侵袭能力。 Objective To investigate the role of cyclin- dependent kinase 2- associated protein 1(CDK2AP1) in migration and invasion of human breast cancer cells. Methods Recombinant lentivirus pGCLV- CDK2AP1- shRNA and negative control pGCLV- GFP were constructed and transfected to human breast cancer MCF- 7 cells. Migration and invasion ability of MCF- 7 cells were determined with xCELLigence system and Transwel chamber assay, respectively. Results Recombinant lentivirus pGCLV- CDK2AP1- shRNA and negative control pGCLV- GFP were transfected into MCF- 7 cells successful y. After transfection, expression levels of CDK2AP1 mRNA in MCF- 7 cells were reduced significantly(P〈0.05). Compared to control MCF- 7/RNAi- NC cells, MCF- 7/RNAi- CDK2AP1 significantly decreased the migration and invasion ability of MCF- 7 cells. Conclusion Si-lence of CDK2AP1 significantly inhibits migration and invasion of human breast cancer MCF- 7 in vitro.
出处 《浙江医学》 CAS 2014年第12期1034-1037,共4页 Zhejiang Medical Journal
基金 宁波市自然科学基金资助项目(2010A610046)
关键词 乳腺癌 CDK2AP1shRNA 细胞迁移 细胞侵袭 Human breast cancer CDK2AP1 shRNA cellMigration cellInvasion
  • 相关文献

参考文献11

  • 1Lee Y T. Breast carcinoma: pattern of metastasis at autopsy[J] Surg. Oncol, 1983, 23(3):175-180.
  • 2Weigelt B. Peterse J L, vant Veer L J. Breast cancer metastasis markers and models[J], Nat Rev Cancer,2005,5(8):591-602.
  • 3Steeg P S. Tumor metastasis: mechanistic insights and clinical challenges[J]. Nat Med, 2006,12(8): 895-904.
  • 4Daigo Y, Suzuki K, Maruyama O, et al. Isolation, mapping and mu- tation analysis of a human cDNA homologous to the doc- 1 gene of the Chinese hamster, a candidate tumor suppressor for oral can- cer[J]. Genes Chromosomes Cancer, 1997, 20(2):204-207.
  • 5Shintani S, Ohyama H, Zhang X, et al. p12 (DOC-1) is a novel cy- clin-dependent kinase 2-associated protein[J]. Mol Cell Biol, 2000, 20(17):6300-6307.
  • 6Figueiredo M L, Kim Y, St John M A, et al. p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer[J]. Clin Cancer Res, 2005, I1(10):3939- 3948.
  • 7Figueiredo M L, Dayan S, Kim Y, et al. Expression of cell-cycle regulator CDK2-associating protein 1 (p12CDK2AP1) in trans- genic mice induces testi cular and ovarian atrophy in vivo[J]. Mol Reprod Dev, 2006,73(8):987-997.
  • 8Yoshida N, Toyama E, Hayashi N, et al. p12CDK2-AP1 is associ- ated with tumor progression and a poor prognosis in esophageal squamous cell carcinoma[J]. Oncol Rep, 2009, 22(1 ):35-39.
  • 9Choi M G, Sohn T S, Park S B, et al. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues[J]. Eur Surg Res, 2009, 42(4):223-229.
  • 10Todd R, McBride J, Tsuji T, et al. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene[J]. FASEB J, 1995, 9(13): 1362-1370.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部